Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 44 for “"allo-HSCT"”.

  1. Επίπτωση και παράγοντες κινδύνου της αιμορραγικής κυστίτιδας (HC) σε παιδιατρικούς ασθενείς μετά από αλλογενή μεταμόσχευση αιμοποιητικών κυττάρων (allo-HSCT)

    Εισαγωγή: Η αιμορραγική κυστίτιδα (ΑΚ) μπορεί να είναι μια σοβαρή επιπλοκή στη μεταμόσχευση αιμοποιητικών κυττάρων (ΜΑΚ). Παρόλαυτα ο λόγος και ο προσδιορισμός των παραγόντων κινδύνου ειδικά όσο αφορά στους παιδιατρικούς ασθενείς δεν είναι ξεκάθαρη και χρήζει επιπλέον διερεύνησης. Υλικό - Μέθοδοι: …

    athens Repository record for Επίπτωση και παράγοντες κινδύνου της αιμορραγικής κυστίτιδας (HC) σε παιδιατρικούς ασθενείς μετά από αλλογενή μεταμόσχευση αιμοποιητικών κυττάρων (allo-HSCT) (opens in a new tab)

  2. The vasculature and immune cell reconstitution of the bone marrow niche after allogeneic hematopoietic stem cell transplantation

    … malignant diseases of the hematopoietic system, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment option. Unfortunately, more than half of the patients receiving allo-HSCT die within the first two years. A major reason for mortality after allo-HSCT is …

    fu-berlin Repository record for The vasculature and immune cell reconstitution of the bone marrow niche after allogeneic hematopoietic stem cell transplantation (opens in a new tab)

  3. Anti-Aspergillus-IgG-Bestimmung zur Vorhersage der pulmonalen invasiven Aspergillose nach allogener Stammzelltransplantation

    … schwerwiegende Komplikation bei Patienten nach allogener Stammzelltransplantation (allo-HSCT). Um eine IA durch die Inhalation luftgetragener Sporen zu verhindern, werden in allen Transplantationszentren Luftfiltersysteme eingesetzt. In aktuellen Veröffentlichungen wurde demonstriert, dass die …

    fu-berlin Repository record for Anti-Aspergillus-IgG-Bestimmung zur Vorhersage der pulmonalen invasiven Aspergillose nach allogener Stammzelltransplantation (opens in a new tab)

  4. Treatment Outcomes in Children with Very High Risk Acute Lymphoblastic Leukemia Intended to Treat with Allogeneic Hematopoietic Stem Cell Transplantation

    … in spite of intensive chemotherapy. Recently, allogeneic hematopoietic stem cell transplantation (Allo-HSCT) was use to treat the patients with VHR ALL. We studied the clinical course and outcomes of children with VHR ALL intended treat with Allo-HSCT after chemotherapy. 16 children who were …

    ajou Repository record for Treatment Outcomes in Children with Very High Risk Acute Lymphoblastic Leukemia Intended to Treat with Allogeneic Hematopoietic Stem Cell Transplantation (opens in a new tab) Embargoed until 9999-12-31

  5. Contribution to the study of the immune response to the BNT162b2 vaccine in allogeneic hematopoietic stem cell transplant

    Allogeneic Hematopoietic Stem Cell transplantation (allo-HSCT) is the best treatment option for patients affected by different kinds of blood diseases, especially malignancy. It consists in the graft of new hematopoietic stem cells (HSCs) from a selected donor into a receiver so to create a new …

    liege Repository record for Contribution to the study of the immune response to the BNT162b2 vaccine in allogeneic hematopoietic stem cell transplant (opens in a new tab) Restricted access

  6. Μελέτη της επίδρασης της μεταμόσχευσης αιμοποιητικών κυττάρων στο αγγειακό ενδοθήλιο

    Introduction: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only treatment option for a variety of malignant and non-malignant hematological diseases. However, during allo-HSCT, the endothelial cells (ECs) of the body's vessels face multiple challenges, resulting in …

    greece Repository record for Μελέτη της επίδρασης της μεταμόσχευσης αιμοποιητικών κυττάρων στο αγγειακό ενδοθήλιο (opens in a new tab)

  7. Einfluss von Anti-Thymozyten-Globulin und Defibrotid auf die Proliferation, Migration und angiogene Aktivität von Endothelzellen

    EINLEITUNG: Die allogene hämatopoietische Stammzelltransplantation (hematopoietic stem cell transplantation, allo-HSCT) ist eine Standardtherapie zur Behandlung von akuten Leukämien und anderen hämatologischen Neoplasien. Wesentliche Komplikationen der allo-HSCT sind Graft-versus-Host-Disease …

    fu-berlin Repository record for Einfluss von Anti-Thymozyten-Globulin und Defibrotid auf die Proliferation, Migration und angiogene Aktivität von Endothelzellen (opens in a new tab)

  8. MICRORNA-21 REGULATES CELL-INTRINSIC DONOR T CELL ALLOREACTIVITY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for blood cancers. Its efficacy depends on donor T lymphocytes recognizing and eliminating residual malignant cells through the graft-versus-leukemia (GVL) effect. However, up to 50% of recipients develop …

    jhu Repository record for MICRORNA-21 REGULATES CELL-INTRINSIC DONOR T CELL ALLOREACTIVITY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (opens in a new tab) Embargoed until 2028-05-01

  9. Eine vergleichende Untersuchung unterschiedlicher Strategien der Darmdekontamination bei der allogenen Stammzelltransplantation

    … des intestinalen Mikrobioms auf die allo HSCT sind komplex und bis heute noch nicht vollständig verstanden. Es bleibt umstritten, inwieweit eine hohe Diversität des Mikrobioms zu einem verbesserten Outcome, zu geringeren Raten an GvHD sowie an Infektionen führt. Vor diesem Hintergrund …

    cau-kiel Repository record for Eine vergleichende Untersuchung unterschiedlicher Strategien der Darmdekontamination bei der allogenen Stammzelltransplantation (opens in a new tab)

  10. Initiation of Acute Graft-versus-Host Disease by Angiogenesis

    … diseases of the hematopoietic system, the allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment option. Accordingly, the number of allo-HSCTs performed worldwide has increased greatly in the past decades. However, the mortality after allo-HSCT is …

    fu-berlin Repository record for Initiation of Acute Graft-versus-Host Disease by Angiogenesis (opens in a new tab)

  11. Epstein-Barr virus in the pathogenesis of post-transpant lymphoproliferative disease

    … and PTLD amongst patients undergoing allogeneic haematopoietic stem cell transplant (allo-HSCT) revealed greatly reduced risk amongst patients with Non-Hodgkin lymphoma previously treated with Rituximab. Complementary laboratory studies to explore the pathophysiology of EBV …

    birmingham Download PDF for Epstein-Barr virus in the pathogenesis of post-transpant lymphoproliferative disease (opens in a new tab)

  12. Immune responses to human cytomegalovirus (HCMV) reactivation in allogeneic haematopoietic stem cell transplantation (HSCT)

    Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is commonly used to treat a range of haematological malignancies with Human cytomegalovirus (HCMV) reactivation as one of the major risk factors. HCMV reactivation is crucial as it can lead to HCMV disease and increase mortality. The …

    birmingham Download PDF for Immune responses to human cytomegalovirus (HCMV) reactivation in allogeneic haematopoietic stem cell transplantation (HSCT) (opens in a new tab)

  13. Leucine rich alpha-2-glycoprotein 1 bei akuter Graft-versus-Host Erkrankung: Messung von Serumkonzentrationen und funktionelle Analysen

    Allogenic hematopoetic stem cell transplantation (allo-HSCT) is the only curative therapy for various hematological diseases. Despite improved conditioning regimes and aGvHD prophylaxis acute Graft-versus-Host Disease remains one of the most frequently observed complications after allo-HSCT. …

    fu-berlin Repository record for Leucine rich alpha-2-glycoprotein 1 bei akuter Graft-versus-Host Erkrankung: Messung von Serumkonzentrationen und funktionelle Analysen (opens in a new tab)

  14. Angiogenesis in Graft-versus-Host Disease

    For a variety of hematopoietic diseases, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment option. Due to numerous improvements in the treatment procedure and the constant expansion of indications, the number of transplanted patients has increased rapidly …

    fu-berlin Repository record for Angiogenesis in Graft-versus-Host Disease (opens in a new tab)

  15. IDENTIFICAZIONE DI NUOVE VIE DI SEGNALE E MARCATORI PREDITTIVI DELLA MALATTIA DEL TRAPIANTO CONTRO L'OSPITE DOPO TRAPIANTO ALLOGENICO DI CELLULE STAMINALI EMATOPOIETICHE

    … PATHWAYS AND PREDICTOR BIOMARKERS OF GVHD AFTER ALLOGENEIC HSCT Background and rationale Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative option for patients with hematological malignancies. However, its success is limited by life-threatening …

    milano Repository record for IDENTIFICAZIONE DI NUOVE VIE DI SEGNALE E MARCATORI PREDITTIVI DELLA MALATTIA DEL TRAPIANTO CONTRO L'OSPITE DOPO TRAPIANTO ALLOGENICO DI CELLULE STAMINALI EMATOPOIETICHE (opens in a new tab)

  16. Enhancing regulatory T cell therapy efficacy for acute GVHD prevention

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be a curative option for many hematological disorders. Unfortunately, allo-HSCT efficacy is complicated by graft-versus-host disease (GVHD), a leading cause of morbidity and mortality after transplant. Current GVHD prophylaxis …

    umn Repository record for Enhancing regulatory T cell therapy efficacy for acute GVHD prevention (opens in a new tab)

  17. Applications of data science to investigate risk factors in allogeneic stem cell transplantation

    Allogeneic haematopoietic stem cell transplantation (allo-HSCT) from healthy donors can provide curative therapy for a variety of life-threatening haematological malignancies. However, the risk of relapse, graft-vs-host disease (GvHD), infection, and toxicity remain major causes of mortality. …

    birmingham Download PDF for Applications of data science to investigate risk factors in allogeneic stem cell transplantation (opens in a new tab)

  18. Investigation of the effects of LSD1 inhibition on AML immunogenicity and T cell-mediated immune responses

    … (AML) is an aggressive hematological malignancy. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents a curative treatment option for AML. Alloreactive donor T cells can produce the graft-versus-leukemia (GVL) effect which represents a major therapeutic benefit of allo-HSCT. …

    mcmaster Repository record for Investigation of the effects of LSD1 inhibition on AML immunogenicity and T cell-mediated immune responses (opens in a new tab)

  19. Contribution à l’étude de la maladie du greffon contre l’hôte dans des modèles de souris humanisées

    … des réponses du système immunitaire après une allogreffe de cellules souches hématopoïétiques (allo-HSCT), mettant l'accent sur la prévention de la GVHD et l'amélioration de l'effet GvT. Mes projets englobent une variété d'approches novatrices. Dans une démarche translationnelle, mes …

    liege Repository record for Contribution à l’étude de la maladie du greffon contre l’hôte dans des modèles de souris humanisées (opens in a new tab) Download PDF for Contribution à l’étude de la maladie du greffon contre l’hôte dans des modèles de souris humanisées (opens in a new tab)

  20. Methods to enhance the efficacy of Regulatory T-cell therapies for acute and chronic Graft-versus-Host Disease

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a life-saving, curative treatment for a range of malignant and non-malignant diseases. However, the efficacy of allo-HSCT is significantly reduced by the development of acute and chronic graft-versus-host disease (GVHD). Current GVHD …

    umn Repository record for Methods to enhance the efficacy of Regulatory T-cell therapies for acute and chronic Graft-versus-Host Disease (opens in a new tab)

Page 1 of 3